CELC

Celcuity Inc. NASDAQ Listed Sep 20, 2017

Healthcare ·Biotechnology ·US · celcuity.com

$139.44

Mkt Cap $6.7B

52w Low $9.51 91.8% of range 52w High $151.02

50d MA $116.33 200d MA $86.13

P/E (TTM) -33.2x

EV/EBITDA -30.6x

P/B 65.7x

Debt/Equity 1.9x

ROE -176.1%

P/FCF -34.1x

RSI (14) —

ATR (14) —

Beta 0.42

50d MA $116.33

200d MA $86.13

Avg Volume 739.7K

About

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Geda…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 25, 2026	AMC	-1.06	-0.97	+8.5%	110.22	-0.9%	+4.2%	-3.8%	-1.8%	+3.6%	+2.5%	—
Nov 12, 2025	AMC	-1.02	-0.92	+9.8%	85.15	+0.0%	+1.0%	+8.8%	+8.3%	+7.6%	+10.7%	—
Aug 14, 2025	AMC	-0.90	-1.04	-15.6%	51.89	+2.0%	-0.2%	-0.6%	-5.1%	-6.0%	-2.9%	—
May 14, 2025	AMC	-0.95	-0.86	+9.5%	10.86	+0.0%	-3.1%	-2.3%	-1.6%	-1.9%	-2.4%	—
Mar 31, 2025	AMC	-0.72	-0.85	-18.1%	10.11	-1.5%	-8.1%	-7.4%	-12.5%	-14.4%	-9.4%	—
Nov 14, 2024	AMC	-0.65	-0.70	-7.7%	14.11	-0.3%	-10.3%	-11.7%	-11.6%	-9.4%	-9.8%	—
Aug 14, 2024	AMC	-0.71	-0.62	+12.7%	16.33	+5.8%	-3.4%	+1.3%	+6.1%	+4.3%	+4.0%	—
May 15, 2024	AMC	-0.71	-0.64	+9.9%	17.23	+13.0%	+2.5%	-2.7%	-2.5%	-4.2%	-7.2%	—
Mar 27, 2024	AMC	-0.71	-0.65	+8.5%	18.16	-0.9%	+18.9%	+14.4%	+8.1%	+10.1%	+9.6%	—
Nov 13, 2023	AMC	-0.74	-0.83	-12.2%	10.89	+4.3%	+10.1%	+11.6%	+12.3%	+17.4%	+20.1%	—
Aug 10, 2023	AMC	-0.67	-0.66	+1.5%	10.00	-2.2%	-1.1%	-2.1%	-1.3%	-5.0%	-4.6%	—
May 15, 2023	AMC	-0.65	-0.55	+15.4%	9.58	-6.1%	+3.0%	+4.6%	+3.5%	+5.4%	+10.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 4	H.C. Wainwright	Upgrade	Neutral → Buy	$165	$125.65	$142.81	+13.7%	+15.4%	—	—	—	—
Apr 27	Citizens	Initiates	Mkt Outperform	$150	$121.03	$121.70	+0.6%	+3.8%	-0.8%	-1.7%	+0.3%	+3.8%
Mar 26	Stifel	Maintains	Buy → Buy	—	$110.22	$109.25	-0.9%	+4.2%	-3.8%	-1.8%	+3.6%	+2.5%
Mar 26	Needham	Maintains	Buy → Buy	—	$110.22	$109.25	-0.9%	+4.2%	-3.8%	-1.8%	+3.6%	+2.5%
Mar 17	Needham	Maintains	Buy → Buy	—	$114.90	$115.00	+0.1%	-0.7%	-2.1%	-1.7%	-7.7%	-7.1%
Mar 10	Needham	Maintains	Buy → Buy	—	$113.45	$115.48	+1.8%	+3.2%	+2.0%	-2.4%	+0.7%	+1.3%
Dec 2	Jefferies	Maintains	Buy → Buy	—	$98.49	$100.00	+1.5%	-1.0%	+1.5%	+7.5%	+7.2%	+5.6%
Nov 17	HC Wainwright & Co.	Downgrade	Buy → Neutral	—	$92.68	$90.40	-2.5%	-0.5%	-1.2%	+1.7%	+1.4%	+5.2%
Nov 13	Craig-Hallum	Maintains	Buy → Buy	—	$85.15	$85.15	+0.0%	+1.0%	+8.8%	+8.3%	+7.6%	+10.7%
Nov 13	Stifel	Maintains	Buy → Buy	—	$85.15	$85.15	+0.0%	+1.0%	+8.8%	+8.3%	+7.6%	+10.7%
Oct 22	HC Wainwright & Co.	Maintains	Buy → Buy	—	$65.50	$65.00	-0.8%	+6.9%	+7.7%	+8.4%	+18.3%	+13.6%
Oct 20	Needham	Maintains	Buy → Buy	—	$51.96	$79.23	+52.5%	+35.8%	+26.1%	+34.8%	+35.8%	+36.6%
Oct 3	Needham	Maintains	Buy → Buy	—	$49.42	$49.40	-0.0%	+2.2%	-3.3%	-0.4%	+0.2%	+0.1%
Aug 18	HC Wainwright & Co.	Maintains	Buy → Buy	—	$51.79	$52.69	+1.7%	-0.4%	-5.0%	-5.8%	-2.7%	+1.2%
Aug 15	Needham	Maintains	Buy → Buy	—	$51.89	$52.92	+2.0%	-0.2%	-0.6%	-5.1%	-6.0%	-2.9%
Jul 28	Needham	Maintains	Buy → Buy	—	$13.77	$45.96	+233.8%	+167.2%	+179.6%	+192.7%	+184.5%	+189.8%
Jul 28	Leerink Partners	Maintains	Outperform → Outperform	—	$13.77	$45.96	+233.8%	+167.2%	+179.6%	+192.7%	+184.5%	+189.8%
Jul 28	HC Wainwright & Co.	Maintains	Buy → Buy	—	$13.77	$45.96	+233.8%	+167.2%	+179.6%	+192.7%	+184.5%	+189.8%
Jun 30	Needham	Maintains	Buy → Buy	—	$12.54	$12.92	+3.0%	+6.5%	-0.4%	+4.0%	+10.0%	+6.4%
May 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$10.61	$10.60	-0.1%	+0.8%	+0.4%	-0.1%	+1.3%	-1.6%
May 15	Needham	Maintains	Buy → Buy	—	$10.86	$10.86	+0.0%	-3.1%	-2.3%	-1.6%	-1.9%	-2.4%
Apr 11	Needham	Maintains	Buy → Buy	—	$8.65	$8.64	-0.1%	+6.7%	+12.7%	+16.9%	+15.5%	+18.4%
Apr 1	Needham	Maintains	Buy → Buy	—	$10.11	$9.96	-1.5%	-8.1%	-7.4%	-12.5%	-14.4%	-9.4%
Apr 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$10.11	$9.96	-1.5%	-8.1%	-7.4%	-12.5%	-14.4%	-9.4%
Feb 6	Needham	Maintains	Buy → Buy	—	$12.74	$12.85	+0.9%	-1.2%	-3.8%	-6.8%	-5.0%	-2.6%
Nov 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$14.11	$14.07	-0.3%	-10.3%	-11.7%	-11.6%	-9.4%	-9.8%
Nov 15	Needham	Maintains	Buy → Buy	—	$14.11	$14.07	-0.3%	-10.3%	-11.7%	-11.6%	-9.4%	-9.8%
Oct 7	Stifel	Maintains	Buy → Buy	—	$15.04	$15.22	+1.2%	+1.5%	+1.5%	-4.5%	-3.6%	+0.8%
Aug 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$16.33	$17.27	+5.8%	-3.4%	+1.3%	+6.1%	+4.3%	+4.0%
Aug 15	Stifel	Maintains	Buy → Buy	—	$16.33	$17.27	+5.8%	-3.4%	+1.3%	+6.1%	+4.3%	+4.0%
Aug 15	Needham	Maintains	Buy → Buy	—	$16.33	$17.27	+5.8%	-3.4%	+1.3%	+6.1%	+4.3%	+4.0%
May 31	Needham	Maintains	Buy → Buy	—	$15.10	$15.11	+0.1%	+4.6%	-0.9%	-1.8%	-6.6%	-5.0%
May 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$17.23	$19.47	+13.0%	+2.5%	-2.7%	-2.5%	-4.2%	-7.2%
May 16	Stifel	Maintains	Buy → Buy	—	$17.23	$19.47	+13.0%	+2.5%	-2.7%	-2.5%	-4.2%	-7.2%
May 16	Needham	Maintains	Buy → Buy	—	$17.23	$19.47	+13.0%	+2.5%	-2.7%	-2.5%	-4.2%	-7.2%
Apr 12	Needham	Maintains	Buy → Buy	—	$19.69	$19.60	-0.5%	-7.0%	-8.1%	-12.5%	-13.6%	-16.8%
Mar 28	Needham	Maintains	Buy → Buy	—	$18.16	$18.00	-0.9%	+18.9%	+14.4%	+8.1%	+10.1%	+9.6%
Mar 28	HC Wainwright & Co.	Maintains	Buy → Buy	—	$18.16	$18.00	-0.9%	+18.9%	+14.4%	+8.1%	+10.1%	+9.6%
Mar 28	Craig-Hallum	Maintains	Buy → Buy	—	$18.16	$18.00	-0.9%	+18.9%	+14.4%	+8.1%	+10.1%	+9.6%
Nov 13	Needham	Maintains	Buy → Buy	—	$10.77	$10.89	+1.1%	+1.1%	+11.3%	+12.8%	+13.6%	+18.7%
Sep 22	Needham	Maintains	Buy → Buy	—	$9.94	$9.97	+0.3%	+0.3%	-3.7%	-3.2%	-3.9%	-5.4%
Aug 11	Needham	Maintains	Buy → Buy	—	$10.00	$9.78	-2.2%	-1.1%	-2.1%	-1.3%	-5.0%	-4.6%
May 16	Needham	Maintains	Buy → Buy	—	$9.58	$9.00	-6.1%	+3.0%	+4.6%	+3.5%	+5.4%	+10.6%
Mar 27	Needham	Maintains	Buy → Buy	—	$9.51	$9.55	+0.4%	+13.6%	+9.1%	+8.4%	+8.9%	+7.8%
May 17	Needham	Maintains	Buy → Buy	—	$5.66	$5.83	+3.0%	-2.8%	-2.7%	-0.7%	+0.7%	+18.4%
Oct 8	Canaccord Genuity	Maintains	Buy → Buy	—	$16.95	$17.84	+5.3%	+1.0%	+3.8%	+3.7%	+11.3%	+9.8%
Sep 7	Jefferies	Maintains	Buy → Buy	—	$21.50	$22.83	+6.2%	+1.3%	+1.9%	+1.3%	-1.5%	-0.2%
Jul 29	Cowen & Co.	Maintains	Outperform → Outperform	—	$20.50	$20.99	+2.4%	+3.9%	-3.9%	-1.4%	-0.7%	-2.4%
Jul 27	Needham	Maintains	Buy → Buy	—	$20.68	$21.00	+1.5%	-1.8%	-0.9%	+2.9%	-4.7%	-2.3%
Feb 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$16.46	$16.13	-2.0%	+1.8%	+1.0%	+8.1%	+0.9%	-4.5%

Insider Trades

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
May 4, 2026	Dalvey David	—	Sell	25,000	$140.68	$3.5M	65,000	—	—

Recent Filings

8-K

Unknown — 8-K Filing

CELC's 2025 full-year results and corporate update will reveal cash runway, development progress on oncology therapies, and whether the biotech has sufficient funding for upcoming clinical milestones—critical metrics determining survival probability and stock viability.

Mar 25

8-K · 5.02 !!! Very High

Celcuity Inc. -- 8-K 5.02: Executive Change

Celcuity appointed Mr. Romp to its board of directors, strengthening governance and potentially signaling management's confidence in strategic direction.

Feb 12

Data updated apr 25, 2026 12:39am · Source: massive.com